Loading…

A Rapid and Robust Diagnostic for Liver Fibrosis Using a Multichannel Polymer Sensor Array

Liver disease is the fifth most common cause of premature death in the Western world, with the irreversible damage caused by fibrosis, and ultimately cirrhosis, a primary driver of mortality. Early detection of fibrosis would facilitate treatment of the underlying liver disease to limit progression....

Full description

Saved in:
Bibliographic Details
Published in:Advanced materials (Weinheim) 2018-07, Vol.30 (28), p.e1800634-n/a
Main Authors: Peveler, William J., Landis, Ryan F., Yazdani, Mahdieh, Day, James W., Modi, Raakesh, Carmalt, Claire J., Rosenberg, William M., Rotello, Vincent M.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Liver disease is the fifth most common cause of premature death in the Western world, with the irreversible damage caused by fibrosis, and ultimately cirrhosis, a primary driver of mortality. Early detection of fibrosis would facilitate treatment of the underlying liver disease to limit progression. Unfortunately, most cases of liver disease are diagnosed late, with current strategies reliant on invasive biopsy or fragile lab‐based antibody technologies. A robust, fully synthetic fluorescent‐polymer sensor array is reported, which, rapidly (in 45 minutes), detects liver fibrosis from low‐volume serum samples with clinically relevant specificity and accuracy, using an easily readable diagnostic output. The simplicity, rapidity, and robustness of this method make it a promising platform for point‐of‐care diagnostics for detecting and monitoring liver disease. A fluorescent‐polymer‐based sensor array, capable of distinguishing patients with and without liver fibrosis from a small volume of serum is demonstrated. The robust sensor operates in minutes rather than hours and does not require the cold‐chain transport and storage of the existing antibody‐based techniques, making it an excellent candidate for translation into a point‐of‐care diagnostic tool.
ISSN:0935-9648
1521-4095
1521-4095
DOI:10.1002/adma.201800634